Clinical trial

Telemonitoring to Treat Group 2 Pulmonary Hypertension

NCT04882774

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-04-01

PhasePHASE2

Study timeline

Study start (estimated)2023-04-01Date precision: month

Registry last updated2023-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertension Due to Left Heart Diseaseunresolved

Interventions

Treprostinil DiolamineDRUG

Sponsors & collaborators

Mardi Gomberg -Maitland MD, MSclead sponsor

Ohio State Universitycollaborator

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)collaborator

Mapped research locations

PittsburghPennsylvania, United States1 ColumbusOhio, United States1 Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04882774 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.